Recycling of epidermal growth factor in a human pancreatic carcinoma cell line.
AUTOR(ES)
Korc, M
RESUMO
PANC-1 human pancreatic carcinoma cells readily bound and internalized 125I-labeled epidermal growth factor (EGF). Bound 125I-labeled EGF was then partially processed to a number of high molecular weight acidic species. Percoll gradient centrifugation of cell homogenates indicated that the majority of 125I activity localized to several intracellular vesicular compartments. Both intact EGF and its processed species were subsequently released into the incubation medium. A major portion of the released radioactivity was capable of rebinding to the cell. Only a small amount of bound 125I-labeled EGF was degraded to low molecular weight products, and this degradation was completely blocked by methylamine. This lysosomotropic compound did not arrest either the generation or the extrusion of the major high molecular weight species of processed EGF (pI 4.2). These findings suggest that in PANC-1 cells, bound EGF undergoes only limited processing. Both intact EGF and its major processed species bypass the cellular degradative pathways, are slowly released from the cell, and then rebind to the cell.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=391014Documentos Relacionados
- Epidermal growth factor stimulation of ornithine decarboxylase activity in a human hepatoma cell line.
- Elevated epidermal growth factor receptor gene copy number and expression in a squamous carcinoma cell line.
- Biosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line.
- Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line.
- Nerve growth factor induces neuron-like differentiation of an insulin-secreting pancreatic beta cell line.